Price Prediction: Marvell Will Trade at This Price in 2027

Photo of Vandita Jadeja
By Vandita Jadeja Published

Quick Read

  • MRVL has surged 187% YTD on AI infrastructure demand but sits 24% below its high as data center concentration and insider selling pressure shares.

  • Wall Street's consensus target of $252 lags reality after Murphy raised fiscal 2028 guidance, with the proprietary model projecting a bull case of $352.

  • Hitting $400 by 2027 requires a 64% gain and a 92x forward P/E, only justified if custom XPU wins accelerate EPS beyond current forecasts.

  • The Motley Fool told its subscribers to buy Amazon in 2002, Netflix in 2004, and Nvidia in 2005. Stock Advisor still publishes two new stock picks every month — and over 23 years, has more than quadrupled the S&P 500. Click here to receive the next recommendation.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Price Prediction: Marvell Will Trade at This Price in 2027

© Thinkstock

Marvell Technology has become one of the loudest AI infrastructure stories of the past twelve months, and the numbers back it up. Marvell Technology (NASDAQ:MRVL | MRVL Price Prediction) shares are up 186.61% year to date as custom XPU silicon, 800G/1.6T optics, and 51.2T Ethernet switches ride the hyperscaler capex wave.

CEO Matt Murphy told investors the company is seeing “exceptional AI-related bookings” and just raised the fiscal 2027 and 2028 outlook. The question I want to answer is simple. Can this stock hit $400 by 2027?

MRVL price target

What’s Holding Marvell Back Right Now

Despite the parabolic YTD move, shares have cooled off. Marvell is down 8.85% in the last month and 0.82% on the week, sitting 24% below the 52-week high of $329.88.

The pullback lines up with two real concerns. First, customer concentration risk is real. Data center now accounts for 76% of revenue, and hyperscaler vertical integration is a genuine overhang.

Second, a beta of 2.197 means every macro wobble hits harder here than in a broad index. Add in net insider selling across 129 recent transactions, and the profit-taking narrative writes itself. I do not think that changes the multi-year thesis, but it explains why the tape looks tired.

Wall Street Sees 4% Upside. Our Model Says 16%

Consensus analyst target is $252.26, which is essentially where the stock trades today. The rating breakdown is heavily bullish: 7 Strong Buys, 31 Buys, 5 Holds, and 1 Strong Sell, an 86% bullish share. Our own base case is $282.97 with 90% confidence, implying 16.32% upside, and the bull case runs to $351.97.

The sell side is likely behind the curve. Analysts anchored their targets before management raised the fiscal 2028 outlook. If bookings acceleration is real, the current consensus is a lagging indicator. That is the gap I am trying to price.

MRVL analyst ratings

The Path to $400 Per Share

Reaching $400 from today’s price of $243.27 would require a gain of 64.4%. With forward EPS of $4.36, a price of $400 implies a forward P/E of 92x. Our base case of $282.97 already implies 80x, meaning the bold target requires roughly 12x of additional multiple expansion.

An infographic titled 'MRVL Stock: The Path to $400' on a dark blue background. It visually depicts a progression from 'Current Price (07/10/2026) $243.27' to a 'Base Predicted Price (2027) $282.97', and then to a 'Bold Target (2027) $400.00'. A horizontal progress bar shows an arrow pointing towards 80% to 100%. Below, a section on 'FINANCIALS AT $400 TARGET' lists 'FORWARD EPS $4.36' and 'IMPLIED P/E 91.7x'. The 'UPSIDE % REQUIRED FOR $400' is stated as 64.4%. 'REDDIT SENTIMENT SCORE' is 71.37, with a green badge indicating 'BULLISH'. The 'PRICE SCENARIOS (2027-07-10)' section shows 'BULL CASE PRICE (TrailingBasedPrice) $351.97' in green and 'BEAR CASE PRICE (ForwardPEBasedPrice) $214.64' in red. The data is specified as of Friday, July 10, 2026 at 5:34 AM ET.
24/7 Wall St.

Is that achievable? The forward P/E compression story only works if EPS growth outruns expectations. Q1 FY2027 revenue grew 27.6% YoY to $2.418 billion, and Q2 is guided to $2.70 billion, roughly 35% YoY. Free cash flow jumped 126.8% to $483.1 million.

Murphy said flatly, “We expect revenue growth to continue accelerating each quarter throughout fiscal 2027.” The Celestial AI and XConn deals close the interconnect gap, and the 247Factor adjustment of 1.104, driven by 1.15 sector momentum and 86% analyst bullishness, tells you the setup is aligned. The main risk is a hyperscaler pausing custom silicon orders.

Where Marvell Trades Today vs Its Earnings Power

At $243.27 against forward EPS of $4.36, Marvell trades at roughly 56x forward earnings. That is a premium multiple, priced for durable AI capex growth.

The stock sits between the 52-week low of $61.32 and high of $329.88, and the 10-year return of 2,517.21% shows what compounding at AI-adjacent margins can do. Fiscal 2026 non-GAAP EPS grew 81% to $2.84. If that operating leverage continues, today’s multiple compresses fast.

MRVL price scenario

Is $400 Realistic? Here’s My Take

My read: $400 by 2027 is a stretch, but it is not a fantasy.

It requires a 64.4% gain, driven by three things going right: fiscal 2028 guidance rising again on custom XPU wins, gross margin holding near 59%, and no hyperscaler pulling in-house. What would derail it is a broader semiconductor spending pause. Returns at this level shouldn’t be expected every year, but we’ve outlined the blueprint for how Marvell could reach $400 in 2027.

Contact [email protected] for any questions or corrections.

Photo of Vandita Jadeja
About the Author Vandita Jadeja →

Vandita Jadeja is a financial copywriter who loves to read and write about stocks. She believes in buying and holding for long term gains. Her knowledge of words and numbers helps her write clear stock analysis. She has contributed to several publications, including the Joy Wallet, Benzinga, The Motley Fool and InvestorPlace.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

MRNA Vol: 87,315,627
COIN Vol: 22,740,003
FCX Vol: 29,776,620
ALB Vol: 3,308,526
EL Vol: 6,022,533

Top Losing Stocks

CTRA Vol: 73,319,495
SRE Vol: 5,176,593
EIX Vol: 3,946,409
AEP Vol: 5,247,385
CNP Vol: 7,823,794